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small animals using a UTE sequence and
iron nanoparticles at 4.7, 7 and 9.4 T
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Abstract
Background: To show that 3D sequences with ultra-short echo times (UTEs) can generate a positive contrast
whatever the magnetic field (4.7, 7 or 9.4 T) and whatever Ultra Small Particles of Iron Oxide (USPIO) concentration
injected and to use it for 3D time-resolved imaging of the murine cardiovascular system with high spatial and temporal
resolutions.
Methods: Three different concentrations (50, 200 and 500 μmol Fe/kg) of USPIO were injected in mice and static
images of the middle part of the animals were acquired at 4.7, 7 and 9.4 T pre and post-contrast with UTE
(TE/TR = 0.05/4.5 ms) sequences. Signal-to-Noise Ratio (SNR) and Contrast-to-Noise Ratio (CNR) of blood and static
tissus were evaluated before and after contrast agent injection. 3D-cine images (TE/TR = 0.05/3.5 ms, scan time
< 12 min) at 156 μm isotropic resolution of the mouse cardiopulmonary system were acquired prospectively with
the UTE sequence for the three magnetic fields and with an USPIO dose of 200 μmol Fe/kg. SNR, CNR and signal
homogeneity of blood were measured. High spatial (104 μm) or temporal (3.5 ms) resolution 3D-cine imaging
(scan time < 35 min) isotropic resolution were also performed at 7 T with a new sequence encoding scheme.
Results: UTE imaging generated positive contrast and higher SNR and CNR whatever the magnetic field and the
USPIO concentration used compared to pre-contrast images. Time-resolved 3D acquisition enables high blood
SNR (66.6 ± 4.5 at 7 T) and CNR (33.2 ± 4.2 at 7 T) without flow or motion artefact. Coronary arteries and aortic
valve were visible on images acquired at 104 μm resolution.
Conclusions: We have demonstrated that by combining the injection of iron nanoparticles with 3D-cine UTE
sequences, it was possible to generate a strong positive contrast between blood and surrounding tissues. These
properties were exploited to produce images of the cardiovascular system in small animals at high magnetic fields with
a high spatial and temporal resolution. This approach might be useful to measure the functional cardiac parameters or
to assess anatomical modifications to the blood vessels in cardio-vascular disease models.
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Background
In clinical practice, magnetic resonance angiography
(MRA) enhanced by a gadolinium-based contrast agent is
the gold standard for many applications [1–3] (MRA of
the lower limbs, supra-aortic MRA, dynamic MRA, etc.).
However, the use of this type of contrast agent has
two major disadvantages: 1) intra-venous injection
entails a risk for the patient to develop nephrogenic
systemic fibrosis [4]; 2) first pass extraction and rapid
redistribution into the extracellular space limits the
time-window of imaging enhanced vasculature [5]. One
way to overcome this limitation is to use contrast agents
with higher blood half-life. Some gadolinium-based con-
trast agents have been developed and validated in pre-
clinical models [6].
The use of ultrasmall superparamagnetic iron oxides
(USPIOs) can also appear as a good alternative [7, 8]. In
patients, numerous studies at 1.5 T described the use of
USPIO-based contrast agents for contrast-enhanced
angiography [5, 9] and coronary MR angiography [10].
Similar positive contrast was also obtained at low field
strength (0.5 T) [11]. Recently, ferumoxytol was used at
3 T for contrast-enhanced high resolution imaging of
the cardio-vascular system [12, 13].
In small animals, the use of USPIO-type contrast
agents is even more common, but is rarely applied to
vascular imaging. In fact, they are mostly used for cell
tracking [14, 15] or molecular imaging [16–19]. In
these domains, and for reasons of sensitivity, they are
rather used as T2* negative contrast agents and at high
field strength. Nevertheless, several methods, like off-
resonance saturation (ORS) techniques [20–22], have
been developed to provide a positive contrast with
USPIO-type agents.
These methods use the disturbances of the magnetic
field induced by USPIOs. Their limitation, however, is
that such disturbances can arise from other sources (air/
tissue interface, imperfections in B0 field homogeneity,
etc.). Furthermore, these effects are even more prevalent
at high magnetic fields. They may prevent the use of
these methods for highly resolved angiography at high
magnetic fields commonly used in preclinical studies.
Iron-based contrast agents can produce a positive
effect at high fields for angiography if the T2 and T2*
effects are limited, and their slight T1 effect availed of.
To do this, it is necessary to limit the signal decay
caused by the phase-shifts of the spins surrounding the
USPIOs. This phenomenon is enhanced by significant
and turbulent blood flows in some blood vessels. The
best way to limit this signal decay is to drastically re-
duce the echo times (TEs) of the MRI sequences.
Ultrashort TE (UTE) pulse sequences allow for signal
acquisition with little T2 influence [23] and have been
used to probe the T1 effect generated by USPIO. This
approach has shown great promise for in vivo applica-
tions particularly in the field of quantitative imaging
[24, 25].
The aim of this study was to show that 3D imaging with
ultra-short echo times (TE < 0.050 ms) can generate a
positive contrast for blood other a wide range of magnetic
fields (4.7, 7 or 9.4 T) and USPIO concentrations injected.
This method was combined to a new 3D cine UTE encod-
ing scheme, to provide 3D time-resolved images of the
murine cardiovascular system with either very high spatial
or very high temporal resolutions.
Methods
Magnets and gradient systems
Experiments were performed on 4.7, 7 and 9.4-Tesla Bru-
ker Biospec Systems (Ettlingen, Germany) equipped with
gradient systems capable of 660 mT/m maximum strength
and 110-μs rise time. Two different coil systems were
used, depending on experiments: (a) a mouse-dedicated
probe (birdcage resonator, 35 mm in diameter and 60 mm
long at 4.7 T (static images), 7 T (static images) and 9.4 T
(static and cine images); (b) a volume resonator (75.4 mm
inner diameter, active length 70 mm) operating in
quadrature mode was used for transmission, and a
four-element (2 × 2) phased array surface coil (outer di-
mensions of one coil element: 12 × 16 mm2; total outer
dimensions: 26 × 21 mm2) was used for signal reception
at 4.7 and 7 T for cine imaging.
In-vivo MR experiments
Contrast agents
Three concentrations of Sinerem contrast agent (Guer-
bet, Aulnay-sous-bois, France) were used: 50 μmol Fe/
kg - 2.8 mg Fe/kg, 200 μmol Fe/kg - 11.2 mg Fe/kg,
and 500 μmol Fe/kg - 28 mg Fe/kg. The r1 and r2 for
Sinerem measured in saline were 1.14 ± 0.06 mM−1.sec−1
and 36.46 ± 3.03 mM−1.sec−1 at 4.7 T, 1.13 ± 0.09 mM
−1.sec−1 and 65.21 ± 4.23 mM−1.sec−1 at 7 T and 1.14 ±
0.1 mM−1.sec−1 and 86.23 ± 3.81 mM−1.sec−1 at 9.4 T,
respectively.
Animal preparation
All experimental procedures were approved by the Insti-
tutional Ethics committee for Animal Care and Use at
Bordeaux university, France (Approval No. 5012032-A).
Static imaging
Mice (C57BL/6, n = 3 for each condition, body weights:
21-25 g) were anesthetized with isoflurane (1.0 % in air)
and 100 μL of contrast agent was injected through the tail
vein. Imaging was performed before and after injection of
the contrast agent; total imaging duration was 1 h.
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Cine imaging
Mice (C57BL/ 6, n = 12, body weights: 21–25 g) were
anesthetized with isoflurane (1.0 % in air). The ECG
signal was picked up using electrodes wrapped around
the forelimbs. This signal was converted into a square
trigger pulse by a specific monitoring and gating system
(SA Instruments, Inc., NY, USA) connected to the spec-
trometer. A respiratory sensor was placed under the
animal’s thorax. ECG and respiratory signals were visual-
ized on a user-interface; cardiac rhythm was stabilized
(380–420 beats/min) and anesthesia was regulated by
modifying the proportion of isoflurane inhaled. A 100-μL
volume of 200 μmol Fe/kg was injected through the tail
vein. Images were acquired pre and post injection of the
contrast agents.
MRI parameters
Static imaging
To determine the signal-to-noise ratio and contrast-to-
noise ratio obtained before and after injection of the
three USPIO concentrations at 4.7, 7 and 9.4 T, non-
synchronized images were acquired with 3D UTE
sequences on a large field-of-view (FOV) (extending
from liver to neck). Imaging parameters are indicated
in Table 1.
Cine imaging
3D cine UTE images were acquired at 4.7, 7 and 9.4 T
with an isotropic resolution of 156 μm, hereafter called
“mid-resolution UTE” and at 7 T with an isotropic reso-
lution of 104 μm, hereafter called “high-resolution UTE”.
The acquisition scheme of the triggered prospective
sequence is shown on Fig. 1. The proposed encoding
scheme allows to reconstruct with the same acquisition
datas, either Ncine = R-Rinterval/(4 x TR) High Spatial
Resolution images (HSR), or Ncine = R-Rinterval/TR High
Temporal Resolution (HTR) images.
Half-projections were sampled in a distribution previ-
ously described [26–28], with sampling starting at a pole
of the sphere and spiraling down to the other pole as the
scan progressed.
To reconstruct HSR images, block of 4 consecutive k-
spaces trajectories (named « 1-2-3-4 » for the first R-R
interval, « 5-6-7-8 » for the second R-R interval, …) were
combined to describe a sphere with the maximum num-
bers of projections (52540 per cine). The same encoding
was used for each cine HSR images (HSR1, HSR2, …,
HSR10).
By using each projections per RR-interval individually,
four-times more cine HTR images could be recon-
structed with 4 times-less projections (13135). It corre-
sponds to the sampling trajectory with the same color
code described in Fig. 1c (blue). HTR1, HTR5, …
HTR37 have the same sampling trajectory which slightly
differs from the HTR2, HTR6, … HTR38 red trajector-
ies, HTR3 to HTR 39 green trajectories and HTR4 to
HTR40 magenta trajectories.
This method allows to homogeneously distribute pro-
jections on the surface of the sphere, both in HSR and
HTR images.
Imaging parameters are indicated in Table 1.
Reconstruction procedure
All the UTE data where reconstructed using the follow-
ing procedure: k-space data were regridded with an
oversampling ratio of 2 using a Kaiser-Bessel kernel
[29]. Data were transformed by applying a conventional
fast Fourier transform (FFT). Each phased array re-
ceiver magnitude image was reconstructed using the
Table 1 Imaging parameters used for static and cine images
Static imaging Cine-imaging
Imaging parameters UTE Mid resolution UTE High resolution UTE
Coil/Magnetic Field Volumetric/ 4.7, 7, 9.4 T Volumetric/9.4 T phased array/ 4.7, 7 T phased array/7 T
TR/TE (ms) 4.5/0.031 3.5/0.031 3.5/0.031
Excitation Pulse/ duration (ms) / FA° square / 0.05 / 15° square / 0.05 / 15° square / 0.05 / 15°
Field of view (mm) 30 × 30 × 30 20 × 20 × 20 20 × 20 × 20
Matrix 128 × 128 × 128 128 × 128 × 128 192 × 192 × 192
Number of projections 51360 18144/cine 52540/cine
Resolution (μm) 234 × 234 × 234 156 × 156 × 156 104 × 104 × 104
Bandwith (Hz/Pixel) 781 781 520
Triggering No ECG ECG
Cine images (N) - 10 10
Excitations (N) 1 1 1
Total acquisition time 3 min 51 s 11 min 20 s 32 min 50 s
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method described above, and then combined by a sum
of squares reconstruction.
Image analysis
Signal-to-noise ratio, contrast-to-noise ratio and signal
homogeneity measurements
Igor Pro (Wavemetrics, Lake Oswego, OR) data pro-
cessing software was used to calculate the apparent
signal-to-noise ratio (SNR) for blood, myocardium and
muscle. Apparent SNR was defined as the signal inten-
sity for the Region Of Interest (ROI) divided by the
standard deviation of the noise (measured for an ROI
positioned outside the mouse body).
The contrast-to-noise ratio (CNR) for blood com-
pared to stationary tissue was defined as CNR = SNR
(blood) – SNR (myocardium or muscle). CNR was
measured at the level of the aortic arch and jugular
veins for static imaging, and in the ventricles for cine
imaging.
Signal homogeneity of blood throughout the cycle
was assessed using the measurements of the standard
deviation for the blood signal in the left and right
ventricles and in the aortic arch.
Statistical analysis
Results were compared using an Anova-test. P < 0.05 was
considered for a significant difference.
Volume analysis
Volume analysis was performed on 6 mice with a semi-
automated segmentation procedure on Amira (Visage
Imaging GmbH, Germany) to calculate left ventricular
end-diastolic volume, left ventricular end-systolic volume,
left ventricular stroke volume (LVSV), left ventricular
ejection fraction (LVEF), right ventricular end-diastolic
volume, right ventricular end-systolic volume, right
ventricular stroke volume (RVSV), and right ventricular
ejection fraction (RVEF).
Fig. 1 Acquisition scheme of the 3D ECG-triggered UTE sequence used to reconstruct either 10 High Spatial Resolution cine images or 40 High
Temporal Resolution cine images. a Blocks of 4 Free Induction Decays (FIDs) corresponding to 4 k-space trajectories (named « 1-2-3-4 » for the
first R-R interval, « 5-6-7-8 » for the second R-R interval…) were repeatedly acquired 10 times along one R-R interval. b (up) Point surface showing
the end-point of the acquired half-projections in a 3D k-space and (bottom) the corresponding projections on the kx-ky plane, acquired 10 times
for one R-R interval. The reconstructed images display high space resolution (HSR) and lower time resolution. c (up) Point surface showing the ends of
the first acquired half-projection of each block in a 3D k-space and (bottom) the corresponding projections on the kx-ky plane of the end-point of
trajectories. The reconstructed images display higher time resolution (HR) at the expense of space-resolution. d Projections on the kx-ky plane of the
end-point of the second trajectories of each block used for HTR2, 6,… images in red, the third trajectories of each block used for HTR3, 7, … images in
green and the fourth trajectories of each block used for HTR4, 8, … images in magenta
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Results
Static imaging – pre and post contrast with UTE
sequences
Images were acquired in a zone extending from the liver
to the neck. Three different concentrations of contrast
agents were used, and the images acquired at 9.4 T pre-
and post contrast agent injection with UTE sequences
are shown in Fig. 2. Before injecting the contrast agent,
the blood vessels and the blood inside the ventricles
were not readily visible. After injection of the contrast
agent, whatever the concentration injected, the blood in
the various blood vessels was visible with the UTE
sequence with an intense signal. This signal was highly
homogeneous, whether in zones with high turbulence,
such as the aortic arch (Fig. 2, small arrow), or in blood
vessels with slow-flow, such as the jugular veins. No
artefact related to blood flow or movement was visible
on the images.
It should also be noted that the liver (Fig. 2, dashed
arrow) always appears with a positive contrast and that
its signal increases with USPIO concentration.
The same experiments were performed at 4.7 T, 7.0 T
and 9.4 T, and the signal-to-noise ratio was measured
for blood (aortic arch, jugular vein) and for the muscles.
The blood-to-muscle contrast-to-noise ratios under the
different conditions are indicated in Fig. 3.
Before contrast agent injection, contrast-to-noise ra-
tio was very low (in the range of -2). After injection,
whatever the magnetic field and the concentration of
nanoparticles used, the contrast-to-noise ratio was
always positive, and greater than or equal to 18. In-
creasing the concentration raised the contrast-to-noise
ratio, at all magnetic fields (p < 0.05 for 200 μmol Fe/kg
vs. 500 μmol Fe/kg). The highest concentration gave a
better contrast-to-noise ratio, always greater than 40,
whatever the magnetic field. Increasing the magnetic
field slightly decreased the contrast-to-noise ratio, but
this change was not significant.
It must be noted that for the lowest Sinerem concen-
tration (50 μmol Fe/kg), the contrast varied slightly
during the experiment (data not shown). This tended
to decrease about 30 % over one hour with the UTE
sequence. In contrast, the CNR measurements remained
stable for at least one hour after injection for the two high-
est concentrations of contrast agent.
Cine imaging
Mid-resolution UTE
3D-cine images at 156 μm isotropic resolution were
acquired prospectively with the UTE sequence for the
three magnetic fields tested before and after contrast
agent injection. The intermediate concentration of
contrast agent (200 μmol Fe/kg) was used for the im-
ages shown in Fig. 4, but similar results were obtained
with the highest concentration. Slices were extracted
during systole and diastole in two orientations (short
axis and long axis) and are shown for the three mag-
netic fields. The acquisition times for these images
were around 12 min.
Before injection, a contrast to noise ratio around -3
was obtained. After injection, and whatever the mag-
netic field, a positive contrast between myocardial
blood and the myocardial wall was obtained at all times
throughout the cardiac cycle (Table 2). The signal was
also highly homogeneous, in both the blood vessels and
in the heart cavities. For example, during a given ex-
periment at 7 T, the standard deviation of the signal
measured in the ventricles and the aortic arch during
Fig. 2 3D UTE images at 9.4 T showing the heart and the liver of a mouse. Images were acquired before and after injection of USPIO at 50, 200
and 500 μmol Fe/kg, without cardiac or respiratory synchronization. The small arrow indicates the aortic arch and the dashed arrow indicates
the liver
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the cardiac cycle gave a value between 1.43 and 2.2
with an apparent SNR of 70.
The images at 4.7 T and 7 T were of comparable quality,
while at 9.4 T the signal-to-noise ratio and the contrast-
to-noise ratio were lower. This discrepancy can be ex-
plained by the use of dedicated 4-channel receiver coils at
4.7 and 7 T only.
High-resolution UTE
Images at 104-μm isotropic resolution were acquired at
7 T (Fig. 5). Such a resolution necessitated 35 min ac-
quisition. As expected, the concentration of contrast
agent was sufficient during the experiment to enable a
very good apparent signal-to-noise ratio for the blood
(40.2 ± 2.3) and a good contrast-to-noise ratio between
the blood and the myocardium (15.8 ± 2.0).
The spatial resolution appears to be effectively im-
proved compared to images acquired at a resolution of
156 μm. This improvement in resolution can be used to
perform precise volumetry (LVSV (μL) = 27.1 ± 3.2;
LVEF (%) = 64.1 ± 4.2; RVSV (μL) = 27.4 ± 3.6; RVEF
(%) = 61.8 ± 5.2).
It can also be used to better appreciate the deforma-
tions of the aortic arch during the cardiac cycle and to
distinguish aortic valve (arrowheads, Fig. 5a N°6) and to
track the left and right coronary arteries (arrows,
Fig. 5b).
Movies showing the 4D-cine images are available as
Additional file 1, Additional file 2, Additional file 3 and
Additional file 4.
Finally, with the acquisition method used, although it
decreases the spatial resolution and the signal-to-noise
ratio due to 4 times less number of projections per
cine, it is also possible to reconstruct a greater number
of images per cardiac cycle. In the videos shown in
Additional file 3 and Additional file 4, forty images
were reconstructed per R-R interval.
Discussion
This article demonstrates that by combining the use of a
UTE 3D imaging sequence with USPIO-based contrast
agents it is possible to achieve a strong Signal-to-Noise
Ratio and a strong positive contrast at high magnetic fields
(4.7 and 9.4 T), and thus to generate highly temporally
Fig. 3 Contrast-to-noise ratio between blood in the aortic arch and muscle, obtained with UTE sequences before and after injection of USPIO at
4.7, 7 and 9.4 T and for different injection doses (200 and 500 μmol Fe/kg). p values lower than 0.05 are indicated by an asterisk
Fig. 4 3D ECG-gated cine image of a mouse heart at 156 μm isotropic resolution obtained before (at 7 T) and after injection of USPIO at 200 μmol
Fe/kg (at 4.7, 7 and 9.4 T). Ten images per cardiac cycle were generated, the images at the end of diastole (left) and systole (right) are shown in
two orientations (short axis: upper panels; long axis: lower panels). No respiratory gating was used
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and spatially resolved images of the cardiovascular system
in small animals.
The term “apparent SNR” instead of SNR was used in
this article because the method of SNR calculation did
not take into account the spatial variance of noise of
phased-array coils. However, as mentioned by Kellman
et al. [30], this spatial variation is important only when
parallel reconstruction is used which was not the case in
our experiments.
We believe that the contrast obtained here is greater
than those described to date in the literature on mouse
cardiac MRI [31–34].
Up to now, iron nanoparticles have mainly been used
through their T2* effect, which allows their presence to
be detected at high magnetic fields (≥4.7 T), in particular
in the field of cellular imaging. Recently, Strobel et al.
[35] exploited the T1 effect of iron oxide particles to
detect pulmonary inflammation. However, in these ex-
periments, the increase in signal for the lung appears
weak, probably due to a low concentration of contrast
agent in the observed zone.
At 3 T, Girard et al. [24] showed that, with a subUTE
sequence, it is possible to have a positive T1 effect and
to exploit it to demonstrate tumor targeting in vivo. At
lower magnetic fields (< 3 T) [6, 36, 37], and recently at
3 T [12, 13], iron nanoparticles have been shown to be
good contrast agents for angiography with classical
gradient echo sequences.
In these studies, to limit the susceptibility effect,
contrast agent was injected at doses between 50 and
100 μmol Fe/kg. At high magnetic fields, as used here,
a dose of 50 μmol Fe/kg gives a positive contrast with a
UTE sequence. However, this contrast is lower than
with other concentrations and decreases over time. It can
therefore limit the acquisition of high-resolution images
because a high contrast is necessary during more than
30 min.
With higher doses of injections, the contrast-to-noise
ratio was significantly increased for all magnetic fields,
Table 2 CNR values between the blood in the ventricles and
the myocardial wall obtained with the UTE sequence at 156 μm
isotropic resolution without USPIO and after injection of USPIO
at 200 μmol Fe/kg
CNR (left
ventricule - left
myocardium)
End-diastole End-systole
UTE 4.7 T without USPIO −2.6 ± 0.6 −4.0 ± 0.9
USPIO 200 μmol Fe/kg 31.4 ± 3.8 30.2 ± 2.2
UTE 7 T without USPIO −2.5 ± 0.7 −3.9 ± 0.6
USPIO 200 μmol Fe/kg 33.2 ± 4.2 29.2 ± 2.5
UTE 9.4 T without USPIO −2.1 ± 0.5 −3.9 ± 0.9
USPIO 200 μmol Fe/kg 16.3 ± 5.8 15.2 ± 3.2
Fig. 5 a 3D ECG-gated cine image as a function of cardiac cycle, obtained at 7 T at 104 μm isotropic resolution after injection of USPIO at
200 μmol Fe/kg. Short axis: upper panel; long axis: lower panel. No respiratory gating was used. The arrow (image 6) indicates the aortic valve. b
Slices extracted from a 3D volume showing the coronary arteries (right coronary arteries: arrow in upper image; right coronary arteries and left cor-
onary arteries: arrows lower image). The scale-bar represents 1 cm
Trotier et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:53 Page 7 of 10
and it remained constant for a duration compatible
with high-resolution cardiac cine image acquisition (>
40 min). Although the doses injected in this study were
higher than the doses used for clinical angiography,
they remained significantly lower than the doses used
for in-vivo targeting imaging (1000 μmol Fe/kg) [37].
Compared to gadolinium chelate-type contrast
agents, the major advantage of iron nanoparticles is
their much longer half-life in the blood, which permits
3D-cine acquisition in small animal. Other gadolinium-
based contrast agents have been developed which have
a longer half-life. For example, reports are given for
p846 [6], a blood pool contrast agent consisting of a
single gadolinium ion in a macrocyclic 3-armed chelate,
developed by Guerbet (Aulnay-sous-bois, France), or
gadolinium-loaded liposomes [31, 32]. However, none
of these agents has been approved for clinical use, and
their long-term innocuousness has yet to be confirmed.
In contrast, a large variety of iron-based nanoparticles has
been developed with various sizes, coating compounds
and surface charges (Sinerem ®, Endorem ®, P904 ® from
Guerbet, Resovist ® and Supravist ® from Bayer Schering,
Clariscan ® from Amersham Health and Ferumoxytol ®
from AMAG Pharmaceuticals, …) [38] and tested on
small animals or humans. Among them, P904 is still avail-
able for preclinical imaging (Chematech, Dijon, France).
Ferumoxitol has recently gained in interest in clinical MRI
[39] due to its U.S. FDA approval as an iron supplement
for patients with chronic kidney disease. Moreover, its
higher relaxivity compared to Sinerem (r1 = 2 mM−1 s−1 at
7 T [25]) combined with a prolonged circulating half-life
(14–15 h), should make it an excellent contrast agent for
high field MRI.
Since such contrast agents are strongly paramagnetic,
ultra-short echo times are needed to achieve significant
positive contrast. The UTE sequence used in this study
has several advantages. The use of radial encoding with
sampling from the center of the k-space, combined with
3D imaging without slice selection and the use of a short
excitation pulse (50 μs) makes it possible to generate
extremely short TEs, less than 0.05 ms in this study. In
small animals, this type of sequence has already been
used for 2D-cine cardiac imaging and makes it possible
to observe a time-of-flight effect. However, resolution of
2D MRI is often limited in the third dimension of space,
and the TE is increased (> 0.3 ms), which can limit its use-
fulness when a contrast agent with a strong susceptibility
effect is injected.
The other advantage of UTE sequences is their low
sensitivity to several artefacts due to motion or blood
flow. Thus, the signal from blood in areas particularly
prone to turbulent flow appears quite homogeneous.
This makes it possible to unambiguously measure the
volume of the ventricles, whereas in conventional
bright-blood images measurements can be affected by
errors due to signal loss caused by significant phase-
shifts of the spins in blood. The method presented here
(UTE + USPIO) could thus be used for phase imaging
in regions of extremely turbulent blood flow. Kadbi et
al. [40] have already demonstrated the efficacy of UTE
sequences to measure blood flow. However, to obtain a
significant time-of-flight effect, they had to introduce a
slice selection into the UTE sequence, thus increasing
the value of TE. The method used here, using both
non-selective volume excitation and USPIO injection,
allows shorter TE and would be also useful for blood
flow quantification.
Finally, we have shown that the combination of the
3D UTE sequence with the injection of an USPIO-type
contrast agent makes it possible to generate very high
spatial resolution, even though iron-based nanoparti-
cles are known to diminish this resolution, particularly
at high magnetic fields. Thus, by using significantly
lower voxel sizes than those used to date in the litera-
ture [34, 41], a particularly precise ventricular volume
can be determined (with semi-automated segmenta-
tion) in a relatively short acquisition time (around
12 min for a resolution of 156 μm, and around 35 min
for a resolution of 104 μm). This should make it possible
to study numerous models of heart diseases. In addition,
the coronary arteries (right and left) are clearly visible at
high resolution (Fig. 5b) as a function of the heart rate,
whereas previous coronary images in small animals were
acquired only during diastole [42, 43].
Among the limitations of the method proposed, the
acquisition time for radial UTE images appears long
compared to classical Cartesian methods, particularly
when high spatial resolutions are necessary. However, as
previously shown [44], radial methods are favorable to
the use of compressed sensing reconstruction algorithms
which can be used to limit the acquisition time.
One caveat of this study is that the doses of contrast
agent used are higher than those commonly used for
USPIO-based angiography in humans. However, they
remain lower than those used in targeting imaging. In
the absence of additional data, it is not possible today to
use these doses as a first-pass agent for angiography in
humans. However, doses between 50 and 100 μmol Fe/
kg combined with 3D UTE imaging sequences, particu-
larly at magnetic fields of 3 T or higher, should make it
possible to image human vascular systems with temporal
and spatial resolution which could be higher than those
currently used in the clinical practice.
Conclusion
In conclusion, we have demonstrated that by combining
the injection of iron nanoparticles with 3D-cine UTE
sequences, it was possible to generate a strong positive
Trotier et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:53 Page 8 of 10
contrast between the blood and surrounding tissues.
These signals and their high contrast were exploited to
produce images of the cardiovascular system in small
animals at high magnetic fields with a high spatial and
temporal resolution. It can be useful for measuring the
functional cardiac parameters or for assessing anatom-
ical modifications to the blood vessels in disease models.
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